asthma

AstraZeneca expanding again in Australia, pledging $133M investment at Sydney site and adding 250 jobs
Fierce Pharma
Fri, 02/7/20 - 11:58 pm
AstraZeneca
Australia
New Zealand
drug manufacturing
asthma
COPD
Novartis axes asthma drug fevipiprant after more trial woes
Pharmaforum
Mon, 12/16/19 - 10:56 am
Novartis
asthma
fevipiprant
clinical trials
Sanofi says Dupixent could be a $10 billion drug, aims to sell Cialis and Tamiflu over the counter
Stat
Mon, 12/9/19 - 11:27 pm
Sanofi
Dupixent
asthma
Cialis
Tamiflu
With EMA review in progress, Novartis unveils more positive data on asthma therapy
Endpoints
Fri, 12/6/19 - 10:27 am
Novartis
EMA
asthma
QMF149
clinical trials
Chasing Mylan, Hikma tries again with rejected generic Advair in US
Pharmaforum
Wed, 11/27/19 - 10:47 am
Hikma
FDA
generics
GSK
Advair
asthma
COPD
Which asthma biologic do docs prefer? It's not that simple: analyst
Fierce Pharma
Sat, 11/23/19 - 03:47 pm
asthma
Roche
Novartis
Xolair
Sanofi
Regeneron
Dupixent
physicians
Novartis downplays late-stage asthma drug failures
BioSpace
Wed, 10/23/19 - 10:31 pm
Novartis
asthma
clinical tirals
fevipiprant
Novartis' asthma drug fails in phase 3, raising doubts about Gossamer's prospects
Fierce Biotech
Tue, 10/22/19 - 10:28 am
Novartis
clinical trials
fevipiprant
asthma
Gossamer Bio
FDA green lights AstraZeneca's asthma drug Fasenra for self-administration
Yahoo/Reuters
Fri, 10/4/19 - 10:25 am
AstraZeneca
FDA
asthma
Fasenra
GSK, Innoviva file sNDA to seek US approval for Trelegy Ellipta in asthma
Pharmaceutical Business Review
Fri, 10/4/19 - 09:59 am
GSK
Innoviva
Trelegy Ellipta
asthma
Novartis announces positive results from asthma combinations
Pharmaforum
Mon, 09/30/19 - 10:32 am
Novartis
asthma
QMF149
QVM149
clinical trials
Study Questions Mainstay Treatment For Mild Asthma
NPR
Mon, 08/26/19 - 10:07 am
asthma
mild asthma
steroid inhalers
Microbiome Report
CP WIre
Sat, 07/20/19 - 08:23 pm
microbiome
4D Pharma
Infant Bacterial Therapeutics
necrotizing enterocolitis
asthma
Microbiome Report
Sat, 07/20/19 - 07:20 pm
microbiome
4D Pharma
Infant Bacterial Therapeutics
necrotizing enterocolitis
asthma
Rivals’ disappointing results in asthma trial drag down shares of Anaptys Bio
Stat
Fri, 06/21/19 - 10:00 am
Sanofi
Regeneron
IL-33
asthma
monoclonal antibodies
REGN3500
AnaptysBio
Dupixent
Novartis burnishes prospects for its big asthma drug with positive PhIII data from a similar treatment
Endpoints
Thu, 05/30/19 - 10:07 am
Novartis
asthma
QMF149
clinical trials
Novartis’ inhaled asthma combo QVM149 succeeds in two phase 2 trials
Pharmaceutical Business Review
Fri, 05/24/19 - 10:34 am
Novartis
QVM149
clinical trials
asthma
Novartis' asthma triplet beats GSK's Advair in phase 2 trial
Fierce Pharma
Wed, 05/22/19 - 10:51 am
Novartis
asthma
QVM149
GSK
Advair
clinical trials
AstraZeneca says Symbicort as anti-inflammatory reliever reduces attacks in mild asthma
Pharmaceutical Business Review
Tue, 05/21/19 - 10:41 am
AstraZeneca
Symbicort Turbohaler
asthma
mild asthma
AstraZeneca's Fasenra offers severe asthma patients 2 years of benefits: analysis
Fierce Pharma
Mon, 05/20/19 - 10:12 am
AstraZeneca
Fasenra
severe asthma
asthma
clinical trials

Pages